Scales to evaluate psychosis in Parkinson's disease

被引：0
|
作者：
Goetz, C. G. [1 ]
机构：
[1] Rush Univ, Med Ctr, Neurol Sci, Chicago, IL 60612 USA
来源：
PARKINSONISM & RELATED DISORDERS | 2009年 / 15卷
关键词：
D O I：
10.1016/S1353-8020(09)70045-8
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
O.030
引用
收藏
页码：S9 / S9
页数：1
相关论文
共 50 条
  • [31] Psychosis and depression in Parkinson's disease
    Brandstädter, D
    Oertel, WH
    PARKINSON'S DISEASE, 2002, 1 : 29 - 38
  • [32] Comparison of three scales to evaluate personality traits in Parkinson's disease: which one to use?
    Gison, Annalisa
    Bonassi, Stefano
    Rizza, Federica
    Giaquinto, Salvatore
    EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE, 2019, 55 (02) : 183 - 190
  • [33] Parkinson psychosis rating scale: A practical instrument for grading psychosis in Parkinson's disease
    Friedberg, G
    Zoldan, J
    Weizman, A
    Melamed, E
    CLINICAL NEUROPHARMACOLOGY, 1998, 21 (05) : 280 - 284
  • [34] Pimavanserin for the treatment of Parkinson's disease psychosis
    Friedman, Joseph H.
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (14) : 1969 - 1975
  • [35] PSYCHOSIS IN PARKINSON'S DISEASE: THERAPEUTIC OPTIONS
    Hasnain, M.
    DRUGS OF TODAY, 2011, 47 (05) : 353 - 367
  • [36] Antipsychotics for the management of Parkinson's disease psychosis
    Jethwa, Ketan Dipak
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2017, 32 (04) : 464 - 465
  • [37] Psychopharmacologic management of psychosis in Parkinson's Disease
    Quitangon, GD
    Rosales-Eder, L
    BIOLOGICAL PSYCHIATRY, 2003, 53 (08) : 41S - 42S
  • [38] Treatment of Psychosis and Dementia in Parkinson's Disease
    Goldman, Jennifer G.
    Holden, Samantha
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2014, 16 (03)
  • [39] Pimavanserin for the treatment of Parkinson's disease psychosis
    Chendo, Ines
    Ferreira, Joaquim J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (15) : 2115 - 2124
  • [40] Reply: Rebound psychosis in Parkinson's disease
    Fernandez, HH
    Okun, MS
    MOVEMENT DISORDERS, 2005, 20 (04) : 515 - 515
12345